Organisation paid for research Program year 2025 Source: CMS Open Payments

Tamar Brionez

Neither a doctor nor a teaching hospital

Research payments

$251,951

12 payments

Through program year 2025, Tamar Brionez is reported as receiving $251,951 in research payments, across 12 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$3,268	2
2024	Research	$33,557	2
2023	Research	$18,019	1
2022	Research	$33,040	2
2021	Research	$59,294	2
2020	Research	$73,639	2
2019	Research	$31,135	1

Breakdown

Who paid Research payments · program years 2019–2025

Eli Lilly and Company $251,951 12 payments

Studies the money was for Research payments · program years 2019–2025

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus $133,299 4 payments
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (Sle) $63,808 3 payments
Taltz Psa Observational Study $32,829 1 payment
Taltz Psa Observational Study $18,019 1 payment
Efficacy and Safety of Ixekizumab Or Ixekizumab Concomitantly Administered With Tirzepatide in Adult Participants With Active Psoriatic Arthritis and Obesity Or Overweight: A Phase 3B, Randomized, Multicenter, Open-Label Study (Together-Psa) $3,885 2 payments
A Phase 3 Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity Or Overweight and Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial $111 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.